Biostat offers support in conducting clinical trials starting from Phase I, where preliminary information about the safety of a medicinal product is obtained, through Phase II, where dosage and efficacy of a potential drug are further determined, Phase III, during which findings from previous phases are verified, interactions between the new product and other drugs are studied, and the effects of its long-term use are analyzed, up to Phase IV – registered products.